Table 2 The Prevalence of Nodules and Microfilaria (mf) of the Study Population
Study Community | Rounds of ivermectin | No. of cases examined | Prevalence of nodule careers N; (%) | Prevalence of Mf carriers N;(%) |
|---|---|---|---|---|
Tanfiano | 20 | 38 | 2 (5.3%) | 5 (13.2%) |
Senya | 20 | 41 | 2 (4.9%) | 1 (2.4%) |
Kokompe | 18 | 35 | 5 (14.3%) | 1(2.9%) |
Total | – | 114 | 9 (7.89%) | 7(6.14%) |